Shima Jazayeri

3.4k total citations
82 papers, 2.5k citations indexed

About

Shima Jazayeri is a scholar working on Physiology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Shima Jazayeri has authored 82 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 19 papers in Public Health, Environmental and Occupational Health and 14 papers in Molecular Biology. Recurrent topics in Shima Jazayeri's work include Diet and metabolism studies (14 papers), Obesity, Physical Activity, Diet (8 papers) and Nutritional Studies and Diet (8 papers). Shima Jazayeri is often cited by papers focused on Diet and metabolism studies (14 papers), Obesity, Physical Activity, Diet (8 papers) and Nutritional Studies and Diet (8 papers). Shima Jazayeri collaborates with scholars based in Iran, United States and United Kingdom. Shima Jazayeri's co-authors include Mehdi Tehrani‐Doost, Naheed Aryaeian, Shahryar Eghtesadi, Abolghassem Djazayery, Agha Fatemeh Hosseini, Mahmood Reza Gohari, Farzad Shidfar, Mostafa Hosseini, Vahideh Behrouz and Homayoun Amini‎ and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience and International Journal of Obesity.

In The Last Decade

Shima Jazayeri

79 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shima Jazayeri Iran 29 712 600 372 349 336 82 2.5k
Ferah Armutçu Türkiye 40 809 1.1× 637 1.1× 427 1.1× 491 1.4× 329 1.0× 107 4.5k
Ahmet Gürel Türkiye 34 614 0.9× 445 0.7× 286 0.8× 269 0.8× 278 0.8× 75 3.2k
Hüseyın Özyurt Türkiye 35 873 1.2× 510 0.8× 368 1.0× 163 0.5× 523 1.6× 102 4.0k
Alireza Milajerdi Iran 31 565 0.8× 562 0.9× 407 1.1× 265 0.8× 254 0.8× 116 2.6k
Reza Amani Iran 30 320 0.4× 596 1.0× 453 1.2× 391 1.1× 431 1.3× 147 2.9k
Zdeňka Ďuračková Slovakia 29 701 1.0× 444 0.7× 614 1.7× 134 0.4× 160 0.5× 90 3.2k
Naghmeh Mirhosseini Iran 30 608 0.9× 571 1.0× 465 1.3× 209 0.6× 605 1.8× 64 2.5k
Ömer Akyol Türkiye 37 817 1.1× 563 0.9× 269 0.7× 154 0.4× 516 1.5× 72 4.1k
Décio Sabbatini Barbosa Brazil 38 535 0.8× 1.0k 1.7× 266 0.7× 337 1.0× 197 0.6× 139 4.0k
Orhan Değer Türkiye 32 490 0.7× 304 0.5× 321 0.9× 231 0.7× 165 0.5× 116 3.7k

Countries citing papers authored by Shima Jazayeri

Since Specialization
Citations

This map shows the geographic impact of Shima Jazayeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shima Jazayeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shima Jazayeri more than expected).

Fields of papers citing papers by Shima Jazayeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shima Jazayeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shima Jazayeri. The network helps show where Shima Jazayeri may publish in the future.

Co-authorship network of co-authors of Shima Jazayeri

This figure shows the co-authorship network connecting the top 25 collaborators of Shima Jazayeri. A scholar is included among the top collaborators of Shima Jazayeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shima Jazayeri. Shima Jazayeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nameni, Ghazaleh, et al.. (2024). Soluble receptor of advanced glycation end product as a biomarker in neurocognitive and neuropsychiatric disorders: A meta‐analysis of controlled studies. European Journal of Clinical Investigation. 54(9). e14232–e14232. 3 indexed citations
3.
4.
Shahinfar, Hossein, et al.. (2023). Adherence to the MIND diet is inversely associated with odds and severity of anxiety disorders: a case–control study. BMC Psychiatry. 23(1). 330–330. 17 indexed citations
5.
Alipoor, Elham, Shima Jazayeri, Mostafa Dahmardehei, et al.. (2023). Effect of a collagen-enriched beverage with or without omega-3 fatty acids on wound healing, metabolic biomarkers, and adipokines in patients with major burns. Clinical Nutrition. 42(3). 298–308. 5 indexed citations
6.
Aryaeian, Naheed, et al.. (2023). Hesperidin reduces serum levels of triglyceride after coronary artery bypass graft surgery. Food Science & Nutrition. 11(11). 7145–7154. 4 indexed citations
7.
Jazayeri, Shima, et al.. (2023). Hesperidin reduces depressive symptoms in post‐coronary artery bypass graft patients with mild depression. Food Science & Nutrition. 11(12). 7742–7750. 5 indexed citations
8.
Shahinfar, Hossein, et al.. (2023). Association between empirical dietary inflammatory index, odds, and severity of anxiety disorders: A case–control study. Food Science & Nutrition. 11(10). 6349–6359. 6 indexed citations
9.
Jazayeri, Shima, et al.. (2021). The association between dietary patterns and quality and duration of sleep in children and adolescents: A systematic review. Clinical Nutrition ESPEN. 45. 102–110. 14 indexed citations
10.
Shidfar, Farzad, et al.. (2018). The effect of vitamin D supplementation on plasma levels of anti-aging protein in elderly. Razi Journal of Medical Sciences. 25(9). 84–93.
11.
Yosaee, Somaye, Kurosh Djafarian, Alireza Esteghamati, et al.. (2018). Depressive symptoms among metabolically healthy and unhealthy overweight/obese individuals: a comparative study. Medical Journal of the Islamic Republic of Iran. 32. 549–552. 9 indexed citations
12.
Mousavi, Seyedeh Neda, Shima Jazayeri, Mojtaba Malek, et al.. (2017). Royal Jelly Decreases Blood Pressure, Serum Glucose, and Interleukin-6 in Patients with Type 2 Diabetes on an Iso-caloric Diet. Journal of Nutrition and Food Security. 2(4). 300–307. 7 indexed citations
13.
Jazayeri, Shima, Fatemehsadat Amiri, Mojtaba Malek, et al.. (2016). Effect of Royal Jelly Intake on Serum Glucose, Apolipoprotein A-I (ApoA-I), Apolipoprotein B (ApoB) and ApoB/ApoA-I Ratios in Patients with Type 2 Diabetes: A Randomized, Double-Blind Clinical Trial Study. Canadian Journal of Diabetes. 40(4). 324–328. 32 indexed citations
14.
Mohammadi, Vida, Mohammad Khalili, Shahryar Eghtesadi, et al.. (2015). The effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in men with chronic spinal cord injury: a clinical trial. Spinal Cord. 53(8). 621–624. 39 indexed citations
15.
Shidfar, Farzad, et al.. (2014). The Effects of Virgin Olive Oil-Rich Diet on Fasting Serum Glucose and Lipid Profile in non alcoholic Fatty Liver Patients with Weight Loss Diet. 15(6). 527–537. 2 indexed citations
17.
Azizi-Soleiman, Fatemeh, Shima Jazayeri, Shahryar Eghtesadi, et al.. (2013). Effects of Pure Eicosapentaenoic and Docosahexaenoic Acids on Oxidative Stress, Inflammation and Body Fat Mass in Patients with Type 2 Diabetes. SHILAP Revista de lepidopterología. 12 indexed citations
18.
Zahedi, Hoda, Shima Jazayeri, Reza Ghiasvand, Mahmoud Djalali, & Mohammad Reza Eshraghian. (2013). Effects of Polygonum Cuspidatum Containing Resveratrol on Inflammation in Male Professional Basketball Players. SHILAP Revista de lepidopterología. 23 indexed citations
19.
Tehrani‐Doost, Mehdi, et al.. (2012). Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Australian & New Zealand Journal of Psychiatry. 47(3). 271–275. 118 indexed citations
20.
Jazayeri, Shima, Mehdi Tehrani‐Doost, Seyed Ali Keshavarz, et al.. (2008). Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder. Australian & New Zealand Journal of Psychiatry. 42(3). 192–198. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026